Fact Check: Pfizer Did NOT Halt Production Of The COVID-19 Vaccine Due To Deaths

Fact Check

  • by: Dana Ford
Fact Check: Pfizer Did NOT Halt Production Of The COVID-19 Vaccine Due To Deaths Upgrades

Did Pfizer halt production of the COVID-19 vaccine due to deaths? No, that's not true: The pharmaceutical company said that it's making improvements to a facility in Belgium, resulting in a "temporary reduction in the number of doses delivered." Production didn't stop. The upgrades are expected to boost deliveries starting in mid-February.

The claim appeared in a post (archived here) published to BitChute on January 19, 2021. The post, titled "PFIZER HALT PRODUCTION DUE TO DEATHS", included a video of a man talking directly to the camera. He said:

If you were conspiracy minded like me, you would say it was because [of] the massive amount of deaths. I believe in America, they're looking into over 100 deaths caused by the snake oil, but the mainstream media are telling us that the reason that Pfizer are suspending production is because they're updating their factories and improving production techniques. Maybe. Listen, all things are possible, but it just seems to me a bit too much of a coincidence that the company that's responsible for all these deaths are suspending production.

Users on social media saw this title, description and thumbnail:



Although, when speaking, the man left open the possibility that he was wrong, the headline of the post clearly says Pfizer stopped production because of deaths. That's not true -- for at least two reasons.

One, Pfizer did not halt production; deliveries were temporarily reduced as improvements are being made to a facility in Puurs, Belgium. In a statement, dated January 15, 2021, the company said that it plans to increase deliveries in the near future. The statement read:

To accomplish this, certain modifications of production processes are required now. As a result, our facility in Puurs, Belgium will experience a temporary reduction in the number of doses delivered in the upcoming week. We will be back to the original schedule of deliveries to the European Union beginning the week of January 25, with increased delivery beginning week of February 15 resulting in our ability to deliver the fully committed quantity of vaccine doses in the first quarter and significantly more in the second quarter.

Two, there is no publicly available evidence to support the statement that more than 100 deaths are being investigated in the United States as being the result of the COVID-19 vaccine. There is at least one case under investigation: that of a Florida doctor who died from an unusual blood disorder after receiving the shot. The man in the video provided no source or proof to back up his claim of more than a hundred.

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:

Lead Stories is working with the CoronaVirusFacts/DatosCoronaVirus Alliance, a coalition of more than 100 fact-checkers who are fighting misinformation related to the COVID-19 pandemic. Learn more about the alliance here.

  Dana Ford

Dana Ford is an Atlanta-based reporter and editor. She previously worked as a senior editor at Atlanta Magazine Custom Media and as a writer/ editor for CNN Digital. Ford has more than a decade of news experience, including several years spent working in Latin America.

Read more about or contact Dana Ford

About Us

International Fact-Checking Organization Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion